Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
RIPK2
Introduction
Receptor-interacting serine/threonine-protein kinase 2 is an enzyme that in humans is encoded by the RIPK2 gene.[1][2][3]
This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-κB and inducer of apoptosis in response to various stimuli.[3]
References
References
- ↑ Inohara N, del Peso L, Koseki T, Chen S, Nunez G (Jun 1998). “RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis”. J Biol Chem. 273 (20): 12296–300. doi:10.1074/jbc.273.20.12296. PMID 9575181.
- ↑ 2.0 2.1 Thome M, Hofmann K, Burns K, Martinon F, Bodmer JL, Mattmann C, Tschopp J (Nov 1998). “Identification of CARDIAK, a RIP-like kinase that associates with caspase-1”. Curr Biol. 8 (15): 885–8. doi:10.1016/S0960-9822(07)00352-1. PMID 9705938.
- ↑ 3.0 3.1 “Entrez Gene: RIPK2 receptor-interacting serine-threonine kinase 2”.
- ↑ McCarthy, J V; Ni J; Dixit V M (Jul 1998). “RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase”. J. Biol. Chem. UNITED STATES. 273 (27): 16968–75. doi:10.1074/jbc.273.27.16968. ISSN 0021-9258. PMID 9642260.
Further reading
Further reading
- Medzhitov R, Janeway C (2000). “Innate immune recognition: mechanisms and pathways”. Immunol. Rev. 173: 89–97. doi:10.1034/j.1600-065X.2000.917309.x. PMID 10719670.
- Dufner A, Mak TW (2006). “CARD tricks: controlling the interactions of CARD6 with RICK and microtubules”. Cell Cycle. 5 (8): 797–800. doi:10.4161/cc.5.8.2635. PMID 16582588.
- McCarthy JV, Ni J, Dixit VM (1998). “RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase”. J. Biol. Chem. 273 (27): 16968–75. doi:10.1074/jbc.273.27.16968. PMID 9642260.
- Bertin J, Nir WJ, Fischer CM, et al. (1999). “Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB”. J. Biol. Chem. 274 (19): 12955–8. doi:10.1074/jbc.274.19.12955. PMID 10224040.
- Inohara N, Koseki T, del Peso L, et al. (1999). “Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB”. J. Biol. Chem. 274 (21): 14560–7. doi:10.1074/jbc.274.21.14560. PMID 10329646.
- Navas TA, Baldwin DT, Stewart TA (1999). “RIP2 is a Raf1-activated mitogen-activated protein kinase kinase”. J. Biol. Chem. 274 (47): 33684–90. doi:10.1074/jbc.274.47.33684. PMID 10559258.
- Inohara N, Koseki T, Lin J, et al. (2000). “An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways”. J. Biol. Chem. 275 (36): 27823–31. doi:10.1074/jbc.M003415200. PMID 10880512.
- Ogura Y, Inohara N, Benito A, et al. (2001). “Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB”. J. Biol. Chem. 276 (7): 4812–8. doi:10.1074/jbc.M008072200. PMID 11087742.
- Lee SH, Stehlik C, Reed JC (2001). “Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing”. J. Biol. Chem. 276 (37): 34495–500. doi:10.1074/jbc.M101415200. PMID 11432859.
- Khursigara G, Bertin J, Yano H, et al. (2001). “A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2”. J. Neurosci. 21 (16): 5854–63. PMID 11487608.
- Andersson L, Scharin Tang M (2015). “Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia”. Cardiovasc Res. 107 (4): 478–86. doi:10.1093/cvr/cvv186. PMID 26130752.
- Druilhe A, Srinivasula SM, Razmara M, et al. (2001). “Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins”. Cell Death Differ. 8 (6): 649–57. doi:10.1038/sj.cdd.4400881. PMID 11536016.
- Chin AI, Dempsey PW, Bruhn K, et al. (2002). “Involvement of receptor-interacting protein 2 in innate and adaptive immune responses”. Nature. 416 (6877): 190–4. doi:10.1038/416190a. PMID 11894097.
- Kobayashi K, Inohara N, Hernandez LD, et al. (2002). “RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems”. Nature. 416 (6877): 194–9. Bibcode:2002Natur.416..194K. doi:10.1038/416194a. PMID 11894098.
- Munz B, Hildt E, Springer ML, Blau HM (2002). “RIP2, a Checkpoint in Myogenic Differentiation”. Mol. Cell. Biol. 22 (16): 5879–86. doi:10.1128/MCB.22.16.5879-5886.2002. PMC 133983. PMID 12138198.
- Yoo NJ, Park WS, Kim SY, et al. (2003). “Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1”. Biochem. Biophys. Res. Commun. 299 (4): 652–8. doi:10.1016/S0006-291X(02)02714-6. PMID 12459189.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Chen YR, Clark AC (2003). “Equilibrium and kinetic folding of an alpha-helical Greek key protein domain: caspase recruitment domain (CARD) of RICK”. Biochemistry. 42 (20): 6310–20. doi:10.1021/bi0340752. PMID 12755636.